These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1574012)

  • 1. Effect of gliclazide on platelet-activating factor-induced platelet aggregation in patients with non-insulin-dependent diabetes mellitus.
    Phenekos C; Siafaka-Kapadai A; Trapali M; Botitsi E; Mavris M
    Metabolism; 1992 May; 41(5 Suppl 1):30-2. PubMed ID: 1574012
    [No Abstract]   [Full Text] [Related]  

  • 2. Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus--an effect probably mediated by direct platelet PPARgamma activation.
    Khanolkar MP; Morris RH; Thomas AW; Bolusani H; Roberts AW; Geen J; Jackson SK; Evans LM
    Atherosclerosis; 2008 Apr; 197(2):718-24. PubMed ID: 17765245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.
    Larkins RG; Jerums G; Taft JL; Godfrey H; Smith IL; Martin TJ
    Diabetes Res Clin Pract; 1988 Jan; 4(2):81-7. PubMed ID: 3125029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of gliclazide on platelet function in patients with diabetes mellitus.
    Violi F; De Mattia GC; Alessandri C; Perrone A; Vezza E
    Curr Med Res Opin; 1982; 8(3):200-3. PubMed ID: 7128193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gliclazide: review of metabolic and vascular action].
    Alberti KG
    Diabete Metab; 1994 Nov; 20(3 Pt 2):341-8. PubMed ID: 7828778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mode of action and clinical pharmacology of gliclazide: a review.
    Campbell DB; Lavielle R; Nathan C
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S21-36. PubMed ID: 1794262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gliclazide--a new antidiabetic agent--on blood platelet function in vitro and in vivo.
    Arfors KE; Bergqvist D; Tangen O
    Ups J Med Sci; 1980; 85(1):74-83. PubMed ID: 7385462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of gliclazide on platelet adhesiveness and aggregation in alloxan diabetic rabbits (author's transl)].
    Kuwashima J; Tsuboi T; Komiya M; Fujitani B; Nakamura K; Maeda J; Kaneko H; Yoshida K; Shimizu M
    Yakugaku Zasshi; 1979 Jan; 99(1):59-64. PubMed ID: 430345
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of the sulphonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function.
    Klaff LJ; Vinik AI; Jackson WP; Malan E; Kernoff L; Jacobs P
    S Afr Med J; 1979 Aug; 56(7):247-50. PubMed ID: 121645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of cancer cell stickiness, a model for investigation of platelet aggregation inhibitors in vivo. Effect of the sulfonyl urea derivatives, glibenclamide, gliclazide, and HB180, as well as the carboxylic acid derivative, meglitinide.
    Gastpar H; Weissgerber PW; Enzmann F; Zoltobrocki M
    Res Exp Med (Berl); 1982; 180(1):75-84. PubMed ID: 6805052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: clinical assessment.
    Jennings PE; Scott NA; Saniabadi AR; Belch JJ
    Metabolism; 1992 May; 41(5 Suppl 1):36-9. PubMed ID: 1574014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
    Grzeszczak W; Strojek K
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():38-9. PubMed ID: 8516206
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of tocopherol on platelet aggregation in non-insulin-dependent diabetes mellitus: ex vivo and in vitro studies.
    Wu HP; Tai TY; Chuang LM; Lin BJ; Wang JD; Teng CM
    J Formos Med Assoc; 1992 Mar; 91(3):270-5. PubMed ID: 1354687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM.
    Westerveld HT; de Graaf JC; van Breugel HH; Akkerman JW; Sixma JJ; Erkelens DW; Banga JD
    Diabetes Care; 1993 May; 16(5):683-8. PubMed ID: 8495604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the effects of some sulphonylureas on platelet function.
    King JB; Kalk WJ; Vinik AI; Jackson WP; Bracher M; Jacobs P
    S Afr Med J; 1977 Jan; 51(5):124-6. PubMed ID: 322325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus.
    Antonopoulou S; Fragopoulou E; Karantonis HC; Mitsou E; Sitara M; Rementzis J; Mourelatos A; Ginis A; Phenekos C
    J Med Food; 2006; 9(3):356-62. PubMed ID: 17004898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a New Antioxidant Enoxifol on Platelet Aggregation and Blood Rheological Properties in Rats with Experimental Diabetes Mellitus.
    Kucheryavenko AF; Spasov AA; Anisimova VA
    Bull Exp Biol Med; 2016 Apr; 160(6):759-62. PubMed ID: 27165061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antagonist effects of compounds derived from khellactone on platelet-activating factor.
    Takeuchi N; Kasama T; Mayuzumi K; Tamaru K; Fukaya H; Ohno T; Tobinaga S
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4221-4. PubMed ID: 3245999
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular effects of sulphonylurea agents in circulating lymphocytes of patients with non-insulin-dependent diabetes mellitus.
    Rabbone I; Piccinini M; Curto M; Mostert M; Gamba S; Mioletti S; Bruno R; Rinaudo MT
    Br J Clin Pharmacol; 1998 Mar; 45(3):291-9. PubMed ID: 9517374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gliclazide: metabolic and vascular effects--a perspective.
    Alberti KG; Johnson AB; Taylor R
    Metabolism; 1992 May; 41(5 Suppl 1):40-5. PubMed ID: 1574015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.